StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Leerink Partners Reiterates Outperform Rating on Medtronic, Inc. (MDT): acquisition an "incremental positive"
March 10, 2026 10:30 AM
Leerink Partners analyst Mike Kratky reiterated an Outperform rating and $119.00 price target on Medtronic, Inc. (NYSE: MDT)The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
